Prokidney (PROK) Change in Acquisitions & Divestments (2023 - 2026)
Prokidney's (PROK) quarterly Change in Acquisitions & Divestments came in at $48.7 million in Q2 2026, down 24.38% year-over-year from $64.4 million in Q2 2025, and down 41.61% quarter-over-quarter from $83.4 million in Q1 2026.
Analysis
Prokidney (PROK) Change in Acquisitions & Divestments (2023 - 2026) Analysis & Trends
Prokidney (PROK) has reported Change in Acquisitions & Divestments for 4 consecutive years, with $48.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Acquisitions & Divestments fell 24.38% year-over-year to $48.7 million in Q2 2026; TTM through Jun 2026 was $300.8 million, a 14.48% decrease from a year earlier, with the FY2025 full-year figure at $318.0 million, down 14.96% from the prior year.
- Change in Acquisitions & Divestments was $48.7 million for Q2 2026 at Prokidney, down from $83.4 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $115.2 million in Q3 2024 and troughed at $6.4 million in Q1 2023.
- A 4-year average of $71.4 million and a median of $70.0 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- Across the five-year window, Change in Acquisitions & Divestments soared 1689.99% in 2024 and plunged 35.83% in 2025, its largest moves.
- Over 4 years, Change in Acquisitions & Divestments stood at $75.6 million in 2023, then advanced by 15.46% to $87.3 million in 2024, then plunged by 35.83% to $56.0 million in 2025, then decreased by 13.13% to $48.7 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $48.7 million (Q2 2026), $83.4 million (Q1 2026), and $56.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48.67 Mn |
| Mar 31, 2026 | 83.37 Mn |
| Dec 31, 2025 | 56.03 Mn |
| Sep 30, 2025 | 112.75 Mn |
| Jun 30, 2025 | 64.37 Mn |
| Mar 31, 2025 | 84.87 Mn |
| Dec 31, 2024 | 87.32 Mn |
| Sep 30, 2024 | 115.18 Mn |
| Jun 30, 2024 | 56.67 Mn |
| Mar 31, 2024 | 114.77 Mn |
| Dec 31, 2023 | 75.63 Mn |
| Sep 30, 2023 | 39.42 Mn |
| Jun 30, 2023 | 54.36 Mn |
| Mar 31, 2023 | 6.41 Mn |